(acquired by IBM)
|$2.18 to $73.20||3487%|
|$2.35 to $24.08||925%|
|Cellstar||$1.44 to $13.50||837%|
|Iomega||$3.25 to $13.90||328%|
|Nanophase||$3.75 to $16.75||347%|
|Immunomedics||$1.44 to $29.12||1922%|
|Total Renal Care||$3.12 to $26.95||741%|
|Voxware||$ .90 to $10.31||1046%|
|Corvas||$3.00 to $23.25||675%|
|Cytogen||$2.12 to $17.50||725%|
|Verilink||$3.00 to $14.62||387%|
|GeneLabs||$2.31 to $10.72||364%|
26 ANALYSTS SAY BUY THIS $2.70 PENNY STOCK!
We are about to recommend in our very next Newsletter our first-ever penny stocks pick that is a STRONG BUY/BUY of over two dozen analysts. Never before in our twenty years of Internet publishing have we ever seen anything quite like this. Of course, our current subscribers will know about this on the day it happens, so, if you want to be one of them, SUBSCRIBE NOW!
BTW, the late April penny stocks Newsletter is now live. Featured are a robotics maker and a diagnostics developer (see the box to your right).
"I cannot thank you enough for your excellent newsletter... I do believe I have found a new hobby (and a well paying one, at that), thanks to you!"
— B.K. (Contractor in Saudi Arabia)